Bajaj HealthCare Limited (NSE:BAJAJHCARE)
321.00
-48.35 (-13.09%)
Jul 22, 2026, 3:30 PM IST
Bajaj HealthCare Market Cap
Bajaj HealthCare has a market cap or net worth of 10.87 billion as of July 22, 2026. Its market cap has decreased by -33.57% in one year.
Market Cap
10.87B
Enterprise Value
12.99B
Revenue
6.28B
Ranking
n/a
PE Ratio
61.68
Stock Price
321.00
ChartMarket Cap Chart
Since May 10, 2016, Bajaj HealthCare's market cap has increased from 1.16B to 10.87B, an increase of 839.40%. That is a compound annual growth rate of 24.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 10.87B | -17.08% |
| Dec 31, 2025 | 13.11B | -27.72% |
| Dec 31, 2024 | 18.14B | 74.95% |
| Dec 29, 2023 | 10.37B | -15.46% |
| Dec 30, 2022 | 12.27B | 7.73% |
| Dec 31, 2021 | 11.39B | 85.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RPG Life Sciences | 47.30B |
| Solara Active Pharma Sciences | 27.50B |
| Indoco Remedies | 22.84B |
| Beta Drugs | 22.50B |
| Ind-Swift Laboratories | 20.07B |
| Sakar Healthcare | 19.53B |
| Windlas Biotech | 17.42B |
| Jagsonpal Pharmaceuticals | 15.04B |